Phosphoinositide 3-kinase c (PI3Kc) consists of a catalytic subunit p110c, which forms mutually exclusive dimers with one of the regulatory subunits called p101 and p84/p87 PIKAP . Recently, PI3Kc emerged as being a potential oncogene because overexpression of the catalytic subunit p110c or the regulatory subunit p101 leads to oncogenic cellular transformation and malignancy. However, the contribution of the individual subunits to tumor growth and metastasis and the mechanisms involved are not understood. We therefore individually knocked down the PI3Kc subunits (p84, p101 and p110c) in MDA-MB-231 cells, which reduced in vitro migration of the cell lines. Knockdown of p110c or p101 inhibited apoptosis, Akt phosphorylation and lung colonization in SCID mice. Similarly, the knockdown of p110c and p101 in murine epithelial carcinoma 4T1.2 cells inhibited primary tumor growth and spontaneous metastasis, as well as lung colonization. In contrast, knockdown of p84 in MDA-MB-231 cells enhanced Akt phosphorylation and lung colonization. These findings are the first to implicate differential functions of the two PI3Kc regulatory subunits in the process of oncogenesis, and indicate that loss of p101 is sufficient to reduce in vivo tumor growth and metastasis to the same extent as that of p110c.
Introduction
Class 1 phosphoinositide 3-kinases (PI3Ks) are a family of dual specificity kinases involved in intracellular signaling linking cell surface receptors to important effector functions, such as growth, proliferation, differentiation, survival, intracellular trafficking and chemotaxis (Vanhaesebroeck et al., 2001; Cantley, 2002; Hawkins et al., 2006) . PI3Ks phosphorylate the 3 0 -hydroxyl group of inositol lipids, which in conjunction with other phosphoinositide kinases that phosphorylate the 4 0 -and 5 0 -hydroxyl groups, leads to accumulation of the important second messenger, phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P 3 , PIP 3 ) at the plasma membrane (Gillooly et al., 2001; Vanhaesebroeck et al., 2001; Cantley, 2002) . This provides a mechanism for recruitment of pleckstrin homology domain-containing proteins such as Akt, which bind to PIP 3 , at the plasma membrane, thereby positioning them for further activation (al-Aoukaty et al., 1999; Simonsen et al., 2001; Procko and McColl, 2005) . For example, once bound to PIP 3 , Akt is phosphorylated by phosphoinositide-dependent kinase-1, which enhances Akt kinase activity, resulting in phosphorylation and activation of downstream effectors. (Burgering and Coffer, 1995; Lopez-Ilasaca et al., 1997; Bondeva et al., 1998) . The class 1 PI3Ks function as heterodimers, comprising a catalytic subunit and a regulatory subunit. (Vanhaesebroeck et al., 2001; Wymann et al., 2003) . Class 1A PI3Ks (comprising a p110a, p110b and p110d catalytic subunit and a p85/p55 regulatory subunit) have mainly been implicated in signaling downstream of receptor tyrosine kinases (Dhand et al., 1994; Pons et al., 1995; Walker et al., 1999 Walker et al., , 2000 Deane and Fruman, 2004) . The catalytic subunit of class 1B PI3K is called p110g and associates with one of two regulatory subunits, p101 or p84 (which is also known as p87 PIKAP but for simplicity will be referred to solely as p84 in this paper; Suire et al., 2005) . PI3Kg has been mainly implicated in signaling downstream of G-proteincoupled receptors. The p110g subunit shares the same modular structure as the p110 catalytic subunits of class 1A PI3Ks, consisting of a Ras-binding domain, a C2 domain, a PIK domain and a catalytic domain, whereas the domain structures of p101 and p84 regulatory subunits have not been elucidated.
Biochemical studies have shown that the N-terminus of p110g interacts with the p101 regulatory subunit and both subunits bind to Gbg dimers (Stephens et al., 1997; Deane and Fruman, 2004) . Initially, it was thought that both the N-and C-termini of p101 interact with p110g, but it has since been shown that the N-terminus is essential for p110g binding, whereas the C-terminus is essential for Gbg binding (Leopoldt et al., 1998; Krugmann et al., 1999; Metjian et al., 1999) . Recent work using gene knockout mice has demonstrated that Gbg, p101 and the interaction of Ras with the Rasbinding domain of p110g all have an important and most likely distinct roles in the regulation of PI3Kg activity in vivo (Maier et al., 1999; Brock et al., 2003; Orme et al., 2006; Suire et al., 2006) . The p84 regulatory subunit shares some sequence similarity to p101 in the N-and Ctermini, which are the important regions for p110g and Gbg binding. Both recombinant and endogenous p84 have been shown to bind p110g specifically and with high affinity, which substantially increases the ability of Gbg to stimulate PtdIns(3,4,5)P 3 production.
The roles of p101 and p84 in the regulation of p110g activity, and particularly whether they perform redundant or independent functions are not understood in great detail. It has been suggested that although the Gbg/p110g interaction activates lipid kinase activity, this is dependent on the Gbg/p101 interaction recruiting PI3Kg to the cell membrane (Brock et al., 2003) and investigations in p101 gene knockout mice demonstrate an essential role for p101 in PI3Kg-dependent Akt activation and cell migration both in vitro and in vivo (Suire et al., 2006) . Similar observations have been made with respect to p110g demonstrating the importance of p101/p110g heterodimers in the regulation of PI3Kg activation at the cell membrane and in cell migration (Suire et al., 2006) . In contrast, the role of p84 in the regulation of PI3Kg activity has not been studied in detail.
A recent study provided the first insight into the distinct roles of the two regulatory subunits in PI3Kg-dependent functions in mast cells (Bohnacker et al., 2009) . Bone marrow-derived mast cells from p110g gene knockout mice were found to be deficient in all three subunits of PI3Kg. When knockout mast cells were transfected with p110g, which did not increase levels of p101 or p84, no PI3Kg-dependent response to adenosine was observed as measured by chemotactic migration, activation of Akt and degranulation. Cells with restored p110g expression were then transfected with either green fluorescent protein (GFP)-tagged p101 or p84. Surprisingly, although both the chemotactic response and Akt activation were restored by expression of either p101 or p84 with p110g, only the p84/p110g complex was able to mediate a degranulation response (Bohnacker et al., 2009) .
In addition to the aforementioned biological functions, PI3Ks have also been implicated as oncogenes. For example, PIK3CA, the gene encoding p110a, is mutated frequently in many common cancers and increased expression of p110b and p110d has been observed in the brain, colon and bladder tumors. (Benistant et al., 2000; Knobbe and Reifenberger, 2003; Mizoguchi et al., 2004; Kang et al., 2006; Denley et al., 2008 Denley et al., , 2009 Zhao and Vogt, 2008) . While PI3Kg has been clearly implicated in a number of physiological functions including cell migration and cell homeostasis, emerging data suggest that like the class IA PI3Ks, it may also have a role in cancer. For instance, it has been shown that p110g is specifically overexpressed in human pancreatic intraepithelial neoplasia and ductal carcinoma, which correlates with increased levels of PIP 3 and phosphorylated Akt (Edling et al., 2010; El Haibi et al., 2010) . In addition, recent reports suggest that overexpression alone may render p110 catalytic subunits transforming; overexpression of p110b, p110d or p110g was shown to transform chicken embryo fibroblasts Denley et al., 2008) . The p101 regulatory subunit has also been reported to have oncogenic potential as it was shown to be a common site of retroviral insertion in a mouse model of T-cell lymphomas and overexpression of p101 enhanced the activity of p110g and protected human leukemia cell lines from ultraviolet light-induced apoptosis (Johnson et al., 2007) .
Although these previous data are supportive of an important role for PI3Kg in tumor growth and metastasis, they have not addressed the role of the specific PI3Kg subunits, nor have they defined a possible mechanism by which these subunits may influence cancer progression. Furthermore there is a limited understanding of the level of redundancy of the p101 and p84 subunits with respect to regulation of PI3Kg activity in the context of tumor biology. In the present study we have investigated the role of the three PI3Kg subunits in tumor growth and metastasis using small hairpin RNA (shRNA) in the MDA-MB-231 breast cancer model in vitro and in vivo. Our data clearly indicate that the loss of the p110g catalytic subunit or of the p101 regulatory subunit is sufficient to prevent tumor growth and metastasis in the model systems through effects on cancer cell survival. The observed in vivo results were supported by shRNA knockdown of p101 and p110g in another breast cancer model 4T1.2. In contrast, although shRNA knockdown of p84 inhibited CXCL12-induced migration of metastatic cancer cells in vitro, no effect was observed in tumor cell survival and metastasis was enhanced. Whereas knockdown of p101 or p110g seems to prevent p110g activation, knockdown of p84 lead to constitutive membrane localization of p110g and constitutive PI3Kg activity as shown by Akt phosphorylation. The results of this study implicate PI3Kg in the regulation of growth and metastasis of breast cancer cells, provide an insight into the mechanism of PI3Kg activity and indicate that the two regulatory subunits have different roles in these processes.
Results
PI3Kg regulates anoikis in MDA-MB-231 cells Chemokines have been implicated in tumor development with chemokine networks regulating several different stages of metastasis. Previous work has implicated a role for CXCR4 signaling in metastatic breast cancer cells, in both MDA-MB-231 cells and 4T1.2 breast cancer cell lines (Holland et al., 2006; Williams et al., 2010) . Previously, we have also shown that signaling through CXCR4 and CCR7 promotes metastasis by inhibiting detachment-induced cell death (anoikis) by regulating members of the Bcl-2 family (Kochetkova et al., 2009 ). Loss of anoikis allows cancer cells to survive longer in the absence of extracellular matrix attachment when metastasizing (Valentijn et al., 2004) . PI3Kg has previously been implicated as an important kinase downstream of CXCR4 signaling (Ganju et al., 1998; Sotsios et al., 1999) . Initial experiments have confirmed that MDA-MB-231 cells express p110g (Niu et al., manuscript in preparation). To determine whether PI3Kg is functional downstream of CXCR4 on MDA-MB-231 cells, the cells were treated with specific inhibitors of PI3K and the function was assessed in a Boyden chamber transwell migration assay. When cells were treated with either AS605240 (10 mM), a specific inhibitor of p110g, or Wortmannin (0.1 mM), a pan-PI3K inhibitor, the ability of MDA-MB-231 cells to migrate toward CXCL12 was significantly decreased (Figure 1a) . MDA-MB-231 cells are resistant to anoikis, which may have a major role in their ability to survive in the bloodstream during metastasis. The resistance of these cells to anoikis was examined by preventing attachment using poly-HEMA-coated plates for 48 h. Apoptosis was assessed using two independent methods-the TdT-mediated dUTP nick end-labelling (TU-NEL) assay and cell-cycle analysis with propidium iodide (PI) staining. Cells treated with the PI3K inhibitors, AS605240 or another pan-PI3K inhibitor, LY294002, demonstrated an increased level of apoptosis as determined by the TUNEL assay (Figure 1b) . When MDA-MB-231 cells were treated with the PI3K inhibitors and stained with PI to assess the DNA content of the cells and elucidate changes in cell cycle with a particular focus on Sub-G1 apoptotic cells, a similar increase in the number of apoptotic cells was observed (Figure 1c ; refer to Supplementary Figure 1a for histograms with cell-cycle gating). In summary, MDA-MB-231 cells treated with AS605240 (1 mM) or the pan-PI3K inhibitor LY294002 (20 mM) during 48 h in suspension were more susceptible to anoikis, as indicated by a significant increase in TUNEL-positive cells, a significant increase in Sub-G1 apoptotic cells corresponding to apoptotic cell death. These results demonstrate a clear role for PI3Kg in resistance to anoikis.
shRNA knockdown of p101 or p110g, but not p84, increases the susceptibility of breast cancer cells to apoptosis PI3Kg consists of a p110g catalytic subunit and one of two regulatory subunits, p101 and p84. Although our experiments using AS605240 implicate p110g in the resistance of MDA-MB-231 cells to anoikis, the role of the subunits p101 and p84 in apoptosis has not been investigated. AS605240, although selective for p110g, may also inhibit p110a at the concentrations used in cell-based assays (Barber et al., 2005; Camps et al., 2005) . Therefore, the results obtained with AS605240 were confirmed using shRNA. The shRNA approach had the added advantage of allowing specific investigation of the relative contribution of the two regulatory subunits in addition to that of p110g. Thus, MDA-MB-231 cells were transduced with lentiviral vectors expressing either p84-, p101-or p110g-shRNA. Cells transduced with lentiviral vectors expressing scrambled shRNA were used as controls. Knockdown of protein expression was confirmed by immunoprecipitation and western blot analysis (Figure 2a) . Densitometry of these blots demonstrated approximately a 70% decrease in the level of p84, an 85% decrease in the level of p101 and an 85% decrease in the level of p110g (Supplementary Figure 2 ). The cell lines were then characterized in two in vitro assays, an XTT assay for in vitro proliferation and a soft agar assay for attachment-independent growth. Similar results were obtained in all knockdown and control cell lines (Supplementary Figure 3) . To further elucidate the function of the individual PI3Kg subunits in resistance to anoikis, the TUNEL assay and PI staining described above ( Figure 1 ) were repeated with the transduced knockdown cell lines. After 48 h in suspension, the TUNEL assay showed that knockdown of p101 or p110g results in a statistically significant increase in the percentage of TUNEL-positive cells when compared with the control. However, p84 knockdown had no detectable effect on anoikis ( Figure 2b ). Similarly, when total changes in cell cycle were analyzed by PI staining, p101 or p110g knockdown led to a statistically significant increase in the percentage of Sub-G1 apoptotic cells, whereas knockdown of p84 did not (Figure 2c ; refer to Supplementary Figure 1b for histograms with cell-cycle gating). Western blot analysis of lysates demonstrated a decrease in fulllength poly (ADP-ribose) polymerase (PARP) and an increase in cleaved PARP in lysates from p101 or p110g knockdown cells, whereas p84 knockdown cells maintained full-length PARP (Figure 2d ). The lysates from cells that were serum-starved overnight while adherent and then prevented from attaching for 1 h to capture early signaling events were analyzed by western blot for the presence of phosphorylated Akt (S473). Knockdown of p101 or p110g prevented the activation of phosphorylated Akt in suspension cells when compared with the control cell lines, whereas knockdown of p84 did not affect phosphorylated Akt (S473) levels when compared with control cell lines (Supplementary Figure 4) . Taken together, these findings demonstrate that reduction in the expression of p101 or p110g, but not of p84 in MDA-MB-231 cells increases their susceptibility to anoikis in vitro.
Figure 2 siRNA knockdown of p101 or p110g, but not p84, increases the susceptibility of MDA-MB-231 cells to apoptosis. (a) MDA-MB-231 cells were transduced with lentiviral vectors expressing p84, p101, p110g or scrambled shRNA. Protein knockdown was confirmed by immunoprecipitation followed by western blot for p84, p101 or p110g. The lysate was analyzed by western blot using actin as an input control. Shown is one representative of three independent experiments. (b) Cells were prevented from attaching for 48 h. Apoptotic cells were quantified by FACS using the FlowTACS TUNEL assay and (c) DNA content was assessed within individual cells by propidium iodide staining followed by flow cytometric cell-cycle analysis. The graphs represents N ¼ 4 ± s.e.m. (d) Cells were prevented from attaching for 48 h. Lysates were analyzed by western blot for the presence of proapoptotic PARP and apoptotic byproduct, cleaved PARP. Shown is one representative of three independent experiments. *Po0.05; **Po0.01.
shRNA knockdown of p101 or p110g, but not p84, inhibits phosphorylation of Akt downstream of CXCR4, which correlates with inhibition of p110g translocation to the membrane The knockdown of all three PI3Kg subunits led to a significant decrease in the migration of MDA-MB-231 cells toward CXCL12 in a Boyden chamber transwell chemotaxis assay when compared with control cell lines (Figure 3a) . This finding supports a role for both regulatory subunits and the catalytic subunit downstream of CXCR4 signaling for migration. Phosphorylated Akt is a signaling protein activated downstream of PI3Kg and is used as a readout for PI3K activity. To investigate the effect of knockdown of the PI3Kg subunits on Akt activation, MDA-MB-231 cells were stimulated with CXCL12 (100 nM) and lysed. The lysates were analyzed by western blot for the presence of phosphorylated Akt (S473). Knockdown of p101 or p110g prevented an increase in the level of phosphorylated Akt detected after CXCL12 stimulation when compared with the control. Surprisingly, knockdown of p84 enhanced phosphorylated Akt (S473) levels when compared with control cell lines (Figure 3b ), an effect that was evident in both unstimulated and stimulated cells. Together with the chemotaxis data, these findings demonstrate that the three subunits have a role in cell migration in response to CXCL12, and further that the p84 and p101 regulatory subunits have distinct roles in the regulation of Akt phosphorylation downstream of CXCL12 stimulation. This difference in CXCL12 signaling was further investigated by examining membrane translocation of p110g, which correlates with PI3Kg activation (Brock et al., 2003; Costa et al., 2007) . Cells were stimulated for 5 min with CXCL12 and membrane fractions were prepared by Dounce homogenization in hypotonic buffer followed by ultracentrifugation to pellet the membrane. Membrane samples were analyzed by western blot for the presence of p110g. Knockdown of p84 led to a constitutively high level of p110g in the membrane fraction, whereas only basal levels of p110g were present in the membrane fractions of p101 knockdown cells, regardless of whether or not the cells were stimulated (Figure 3c ).
Decreased expression of p101 or p110g, but not p84, inhibits experimental metastasis of breast cancer in vivo A dual-fluorescence experimental model of metastasis was used to determine whether knockdown of the individual PI3Kg subunits altered the ability of MDA-MB-231 cells to metastasize in vivo (Kochetkova et al., 2009) . Red fluorescent protein-labelled vector control cells and GFP-labelled cells in which p84, p101 or p110g had been knocked down were mixed in equal numbers and injected into the tail veins of female SCID mice. After 8 weeks of growth, mice were sacrificed and the lungs were examined for metastases. As assessed under a fluorescent dissecting microscope, the lungs from mice injected with either p101 or p110g knockdown cells showed a dominance of red fluorescent lesions from control cells over green fluorescent lesions from knockdown-expressing cells (Figure 4a ). Red fluorescent lesions and green fluorescent lesions in each lung were counted and ratios of control lesions to knockdown lesions were calculated and graphed (Figure 4b ). The control group injected with equal numbers of wild-type cells and vector control cells displayed an approximately 1:1 ratio of green to red lesions. This ratio was decreased significantly when green-labelled cells expressed p101 or p110g knockdown, but not when green-labelled cells expressed p84 knockdown.
Decreased expression of PI3Kg inhibits primary tumor growth, spontaneous metastasis and experimental metastasis in the mouse 4T1.2 model of breast cancer The interesting observation that metastasis was inhibited by knockdown of either p101 or p110g in the MDA-MB-231 model was further investigated using shRNA knockdown of p101 and p110g in the 4T1.2 model. The Figure 3 siRNA knockdown of p101 or p110g, but not p84, inhibits phosphorylation of Akt downstream of CXCR4, which correlates with a prevention of p110g translocation to the membrane. (a) MDA-MB-231 cells were added to the upper well of a Boyden Chamber transwell migration assay with CXCL12 (100 nM) in the lower well. Migration index was calculated after a 3 h incubation. The experiment was setup in triplicates and the results shown are N ¼ 3±s.e.m. The experiment was repeated twice with similar results. (b) Cells were serum-starved for 2 h and then stimulated with CXCL12 (100 nM) for 1 and 5 min. Cells were lysed and lysates were analyzed by western blot for the presence of phospho-Akt (S473). Differences in phospho-Akt expression were calculated by densitometry of the blots. Shown is one representative of three independent experiments. (c) Cells were serum-starved for 2 h and then stimulated with CXCL12 (100 nM) for 5 min. Cells were lysed by Dounce homogenization in hypotonic buffer and membrane fractions were pelleted by centrifugation at 100 000 g for 1 h. Membrane fractions were analyzed for the presence of p110g by western blot. Shown is one representative of three independent experiments. *Po0.05.
4T1.2 cell line was subcloned from a spontaneous breast cancer model for the ability of the cells to form metastases in the liver, lungs and bone, which are the common sites of metastasis in human breast cancer (Aslakson and Miller, 1992; Tao et al., 2008) . The cells were transduced with lentiviral vectors expressing p101-or p110g-shRNA and cells transduced with lentiviral vectors expressing GFP shRNA were used as controls. Knockdown of protein expression was confirmed by immunoprecipitation and western blot (Figure 5a) . Densitometry of these blots demonstrated approximately a 70% decrease in the level of p101 and an 80% decrease in the level of p110g (Supplementary Figure 5) . As observed with the MDA-MB-231 cells, loss of expression of the individual PI3Kg subunits did not affect in vitro proliferation or the ability of 4T1.2 cells to form colonies in soft agar in vitro over 2 weeks (Supplementary Figure 6) . Therefore, under standard in vitro conditions in 5% fetal calf serum-supplemented a-minimum essential medium, the transduced cells were able to proliferate and survive to the same extent. To determine the ability of the cells to survive and proliferate in vivo the transduced 4T1.2 cell lines were injected into the mammary fat pads of female Balb/c mice. Tumor growth was monitored for 4 weeks by measurement of the palpable tumors every 2 days. Cells lines in which either of the PI3Kg subunits was knocked down produced smaller primary tumors through the course of the experiment when compared with control cells (Figure 5b ). This result was confirmed after the mice were sacrificed and primary tumors were excised and weighed. Primary tumors derived from cells expressing PI3Kg subunit knockdown were significantly smaller than the control counterparts (Figure 5c ). From the same mice the lungs were also excised and examined for spontaneous surface metastatic nodules. Lungs from ) were injected into the tail veins of 6-to 8-week-old female Balb/c mice. After 2 weeks, the mice were sacrificed and the lungs were excised. The five lobes of each lung were separated and examined under a dissecting microscope for surface metastatic nodules. Bars represent the mean number of surface lung metastases from one representative experiment of three performed. (f) Representative images of lungs excised from mice injected with 4T1.2 cells and a wild-type Balb/c mouse. *Po0.05; **Po0.01; ***Po0.001. mice injected with cell lines expressing PI3Kg knockdown constructs displayed significantly fewer metastatic nodules than their control counterparts (Figure 5d ). The number of spontaneous metastatic lung surface nodules was normalized to the weight of the primary tumor. The data demonstrated that there was no linear correlation between the size of the primary tumor and the number of spontaneous metastic nodules (Supplementary Figure 7) .
Spontaneous metastasis in the 4T1.2 model typically results in a relatively low number of lung surface nodules. Therefore, to determine whether p110g and p101 knockdown inhibits lung colonization with an increased load of tumor cells in this model, Balb/c mice received 5 Â 10 5 4T1.2 cells intravenous and 2 weeks later, the mice were sacrificed and the lungs were examined for surface metastatic nodules. Only a few visible metastatic nodules were observed on the surface of the lungs of mice injected with cells expressing knockdown of p110 or p101 compared with their control counterparts (Figures 5e and f) . The results indicate that PI3Kg has a role in primary tumor formation and metastasis.
4T1.2 cells unfortunately do not respond well to CXCL12 stimulation, so to further investigate the effect of knockdown of the PI3Kg subunits on G-proteincoupled receptor signaling, 4T1.2 cells were stimulated with lysophosphatidic acid (LPA; 1 mm) and lyzed. The LPA receptor (LPA 1 ) is reported to be expressed on 4T1.2 cells and to be involved in both in vitro and in vivo migration by these cells (David et al., 2010; Kim and Adelstein, 2011) . The lysates were analyzed by western blot for the presence of phosphorylated Akt (S473). Knockdown of p101 or p110g prevented an increase in the level of phosphorylated Akt detected after LPA stimulation when compared with the control (Supplementary Figure 8a) . As demonstrated in the MDA-MB-231 cells with CXCL12 (Figure 3) , this difference in LPA signaling was further investigated by examining membrane translocation of p110g. Cells were stimulated for 5 min with LPA and membrane fractions were prepared by Dounce homogenization in hypotonic buffer followed by ultracentrifugation to pellet the membrane. Membrane samples were analyzed by western blot for the presence of p110g. Knockdown of p101 prevented translocation of p110g in the membrane fraction upon stimulation when compared with GFP knockdown control cells ( Supplementary  Figure 8b) .
Discussion
The results of this study provide important insights into the role of PI3Kg, and in particular its regulatory subunits, in tumor growth and metastasis. Although the catalytic subunit p110g and its p101 regulatory subunit have previously been implicated in several types of cancer, our work provides new direct in vivo evidence that p110g and p101 have an important role in primary tumor formation and metastasis, and delves further into the signaling pathways leading to these events by implicating PI3Kg in the control of cancer cell apoptosis, more specifically, of anoikis. Moreover, the results of our studies indicate divergent roles for the regulatory subunits, p101 and p84 in the control of PI3Kg-mediated cell migration and anoikis in metastatic epithelial carcinoma cells.
It is well established that PI3Kg has a role in leukocyte migration (Vanhaesebroeck et al., 2001; Cantley, 2002; Okkenhaug and Vanhaesebroeck, 2003; Deane and Fruman, 2004) and using MDA-MB-231 breast cancer cells as a model system, we have shown that all three subunits of PI3Kg (p101, p84 and p110g) regulate migration of these epithelial carcinoma cells in response to the chemokine CXCL12. However, the mechanisms by which p101 and p84 mediate migration are different. Activation of PI3Kg in response to CXCL12 results in enhanced phosphorylation of Akt, which is required for migration of MDA-MB-231 cells in response to CXCL12 . When p84 expression is reduced by lentiviral shRNA, a high basal level of phosphorylated Akt in the cells and constitutive localization of p110g at the plasma membrane was observed. Akt phosphorylation was further increased in response to CXCL12 stimulation. In contrast, the absence of p101 led to loss of recruitment of p110g to the membrane and prevention of phosphorylation of Akt downstream of CXCR4 stimulation by CXCL12. The question thus arises, how is it possible that knockdown of p84 inhibited CXCL12-induced migration, yet knockdown of p84 led to constitutive recruitment of p110g to the membrane and enhanced Akt phosphorylation in response to CXCL12, events that are considered as hallmarks of PI3Kg activation? Of relevance, it has recently been shown that directional cell migration involving activation of PI3Kg requires the rapid generation of an intracellular [PtdIns(3, 4, 5) ] gradient in the responding cell (Costa et al., 2007) . In that study, transfection of neutrophils with a plasmid encoding p110g-CAAX, a membranetargeted p110g construct that results in constitutive PI3Kg activity and disruption of the ability of cells to form an intracellular [PtdIns(3,4,5)] gradient, similarly led to a loss in chemotaxis of the cells. This may explain why loss of p84 leads to a loss of chemotactic migration-the constitutive activation of p110g evident by its membrane localization and increase in Akt phosphorylation in the p84 knockdown cells affects the ability of the cells to polarize and form a leading edge.
Our data have also uncovered a role for PI3Kg in the regulation of cancer cell apoptosis, more specifically, of anoikis, which is relevant in the context of metastasis of epithelial carcinomas (Bretland et al., 2001; Goldberg et al., 2001; Savagner, 2010) . The role of class IA PI3Ks and, in particular, of the Akt pathway in promotion of cell survival is well documented (Wang, 2004; Tang et al., 2010) . However, it has only recently come to light that PI3Kg may also regulate cell survival, although it must be stated that the majority of evidence is from in vivo studies and while clearly important, does not prove a direct link between PI3Kg and cell survival (Wymann et al., 2003; Johnson et al., 2007; Edling et al., 2010; Rodrigues et al., 2010) . To the best of our knowledge, our data provide the first direct proof of a link between PI3Kg activation, specifically, of p110g and p101, and cell survival, and in particular, in prevention of anoikis in metastatic epithelial carcinoma cells. Anoikis is apoptosis induced upon disruption to or loss of cell-matrix interaction-dependent survival signals. A number of studies indicate that anoikis has a critical role in malignant transformation of a range of tissues, including mammary, colon, prostate and lung epithelial tissues and loss of anoikis is believed to give cancer cells a selective advantage by increasing their survival time in the absence of appropriate extracellular matrix attachment (Valentijn et al., 2004) . In the present study, when adherent MDA-MB-231 cells were treated with AS605240 in serum-free media, no effect was observed on apoptosis (data not shown). This parallels the results of a recent study showing that treatment of adherent, serum-deprived pancreatic cancer cells with a p110g inhibitor did not increase apoptosis (Edling et al., 2010) . However, in the present study, when MDA-MB-231 cells were prevented from attaching and maintained in suspension in the presence of AS605240, a significant increase in apoptosis was observed, indicating a role for PI3Kg in the regulation of anoikis in these cells. Moreover, this effect was observed under the same conditions when p110g and p101 were knocked down using shRNA. MDA-MB-231 cells express a high level of phospholipase D (Zhong et al., 2003) , which has been shown to specifically interact with PIP 3 , enhancing its anti-apoptotic activity (Ching et al., 1999) . Loss of PIP 3 because of loss of PI3Kg activity would in turn lead to a loss of phospholipase D-dependent anti-apoptotic signaling (Yamada et al., 2004; Shi et al., 2007) . Likewise, accumulation of active Akt also has anti-apoptotic effects by upregulating transcription factors that constitutively activate survival genes (Nicholson and Anderson, 2002; Osaki et al., 2004) . In the present study, loss of p84 led to constitutive and enhanced activation of Akt, which may explain why p84 knockdown did not alter the ability of MDA-MB-231 cells to survive in suspension. These observations lead us to hypothesize that PI3Kg-dependent regulation of anoikis is mediated by p101/p110g heterodimer activity. We postulate that p101 and p84 have differential roles in targeting p110g to the membrane downstream of CXCR4 signaling. Moreover, our data indicate that the p101 regulatory subunit is critical for the membrane targeting and subsequent activation of p110g in the MDA-MB-231 cells.
Although there is considerable evidence for the involvement of class IA PI3Ks in oncogenesis (Bader et al., 2006; Kang et al., 2006; Denley et al., 2008 Denley et al., , 2009 Zhao and Vogt, 2008) , the case is less clear for PI3Kg and to the best of our knowledge, ours is the first direct in vivo proof implicating PI3Kg and its individual subunits in tumor growth and metastasis. Previous studies show that p110g is overexpressed in human pancreatic intraepithelial neoplasia and ductal carcinoma, and this correlates with increased levels of PIP 3 and phosphorylated Akt (Edling et al., 2010; El Haibi et al., 2010) . In addition, forced overexpression of p110g was shown to transform chicken embryo fibroblasts Denley et al., 2008) and p101 has been reported to be a common site of retroviral insertion in a mouse model of T-cell lymphomas (Johnson et al., 2007) . Overexpressed p101 also enhanced the activity of p110g and protected human leukemia cell lines from ultraviolet light-induced apoptosis (Johnson et al., 2007) . The MDA-MB-231 SCID model used in the present study therefore provides the first direct in vivo proof of a role for PI3Kg in tumor growth and metastasis. In addition, it showed a clear difference between p84 and p101 in metastatic signaling, with loss of p101 leading to a reduced number of surface metastatic nodules, similar to that observed with loss of the p110g catalytic subunit, whereas loss of p84 did not reduce lung colonization, and in fact, enhanced it. This outcome is consistent with our in vitro data implicating regulation of anoikis as a likely mechanism underlying this difference between p101 and p84. However, the fact that loss of p84 had no effect on anoikis in vitro, yet enhanced the ability of MDA-MB-231 cells to colonize the lung in vivo, remains enigmatic and requires further experimentation.
To further investigate the observation that p110g and p101 drive metastasis, as observed in the MDA-MB-231 model, a second model with additional features was used. The mouse 4T1.2 orthotopic model of breast cancer shares a number of important similarities with human breast cancer including that it mimics the pattern of metastasis of human breast cancer (Lelekakis et al., 1999; Eckhardt et al., 2005) . When injected into mammary fatpads, the 4T1.2 cells form primary tumors and spontaneously metastasize to the lungs, liver and bone (Aslakson and Miller, 1992; Tao et al., 2008) . This allowed evaulation of the effect of knockdown of p110g and p101 on primary tumor growth and spontaneous metastasis in conjunction with experimental metastasis in animals with an intact immune system. Knockdown of p110g or p101 led to a significant attenuation of primary tumor growth and a significant decrease in the number of surface metastatic nodules visible in the lungs in both the spontaneous and experimental metastasis models, thereby confirming and expanding our observations from the SCID mouse model. In summary, we have shown that knockdown of p101 has the same biological effects as knockdown of p110g and is sufficient to inhibit in vivo tumor growth and metastasis. These findings support a crucial role for PI3Kg in breast cancer, and by extension other epithelial carcinomas. In addition, we have shed light on the molecular mechanisms regulating PI3Kg activation and report the novel observations that PI3Kg regulates anoikis in these cells and its regulatory subunits, p101 and p84, have divergent roles in these processes. More detailed understanding of the molecular mechanisms regulating this process will potentially lead to new avenues for cancer drug design.
Materials and methods

Cell lines, antibodies and reagents
The human breast cancer cell line, MDA-MB-231, and the murine breast cancer cell line, 4T1.2, were obtained from the American Type Culture Collection (Manassas, VA, USA). Cells were grown at 37 1C in 5% CO 2 in a humidified atmosphere according to the supplier's instructions. To analyze the effect of a forced detachment, for all assays freshly trypsonized cells were seeded in 0.5% methylcellulose-supplemented RPMI culture media without fetal calf serum onto poly-HEMA-coated dishes from Corning Inc. (Lowell, MA, USA) at a cell density of 2.5 Â 10 5 cells/ml. Bcl-XL, PARP, p110g, Akt and Phospho-Akt (Ser 473) rabbit monoclonal antibodies were from Cell Signaling Technology (Danvers, MA, USA); b-actin mouse monoclonal antibody was purchased from Sigma-Aldrich (St Louis, MO, USA); p101 rabbit polyclonal antibody was purchased from Milipore (Billerica, MA, USA); p110g (clone H1) and p110g (clone 641) mouse monoclonal antibodies were from Jena Bioscience (Jena, Germany). AS605240 from Echelon Biosciences Inc. (Salt Lake City, UT, USA) was used at 1 and 10 mM. Wortmannin was used at 0.1 mM (Sigma-Aldrich) and LY294002 at 20 mM (Calbiochem, San Diego, CA, USA). PI was purchased from Sigma-Aldrich. Synthetic CXCL12 was from the Biomedical Research Centre, University of British Colombia, Vancouver, Canada and used at 100 nM final concentration.
Subcellular fractionation for membrane fractions
Membrane fractions were prepared as described previously (Yu et al., 1995) .
Western blot
Western blot analysis was performed as described earlier (Holland et al., 2006) .
Apoptosis assays
Apoptotic cells were quantified using the FlowTACS Apoptosis Detection Kit (Trevigen Inc., Gaithersburg, MD, USA) according to the manufacturer's instructions. Cell-cycle analysis by flow cytometry was performed as outlined in Riccardi and Nicoletti (2006) .
In vitro survival assay XTT/PMS assay was performed as described previously (Williams et al., 2010) .
Soft agar assay
Soft agar assays were performed as outlined in Williams et al. (2010) .
Boyden chamber chemotaxis assay Chemotaxis was measured in a modified Boyden chamber as described in Akekawatchai et al. (2005) .
Retroviral and lentiviral transductions
MDA-MB-231 cells expressing red fluorescent protein and GFP were generated as described previously (Akekawatchai et al., 2005) . shRNA constructs in pLKO.1 were purchased from Open Biosystems Inc. (Huntsville, AL, USA) and used according to manufacturer's instructions.
In vivo survival and metastasis assays Female 6-to 8-week-old CB-17 SCID mice were purchased from the Animal Resource Centre (Perth, WA, Australia). SCID mice were housed in pathogen-free conditions in the immune-compromised barrier rodent facility at the University of Adelaide Animal House (Adelaide, SA, Australia). Female 6-to 8-week-old Balb/c mice were bred and maintained at the University of Adelaide Animal Facility. Mice were kept under standard light and temperature conditions and fed food and water ad libitum. All procedures performed on mice were in accordance with NH&MRC guidelines and approved by the University of Adelaide Animal Ethics Committee.
For the MDA-MB-231 metastasis assay five SCID mice each received tail vein injections of a total of 3 Â 10 5 cells of 1:1 mixtures of the red fluorescent protein-labelled vector control and the GFP-labelled PI3K knockdown-expressing cells, suspended in 100 ml of sterile phosphate-buffered saline. Mice were sacrificed by CO 2 inhalation at week 8 post injection. Lungs were perfused with phosphate-buffered saline, harvested and imaged by light and fluorescence microscopy using a Leica stereo fluorescence dissection microscope model MZ16FA. Fluorescent metastatic nodules were counted and ratios of red fluorescent protein-to GFP-expressing tumors were calculated.
Balb/c female mice were anaesthetized by isoflurane inhalation and 1 Â 10 5 cells in a 10 ml volume were injected into the 4th left mammary fat pad using a 50 ml Hamilton syringe (Hamilton, Reno, NV, USA). Tumor growth was assessed every second day from day 7 post injection and tumor diameters were measured with digital callipers (Mitutoyo, Japan). Tumor volume was calculated with the equation: width 2 Â length/2. Mice were euthanized once tumor diameter reached 15 mm or tumors became ulcerated. Excised tumors were frozen in liquid nitrogen. To quantify metastasis, lungs were fixed in 4% formaldehyde in phosphate-buffered saline at 4 1C overnight. Lungs were passed through two 30% sucrose baths of 2 h each before being stored immersed in 70% ethanol at 4 1C. Lungs were dissected into five lobes and surface metastases were counted under a dissecting microscope.
For the experimental metastasis model, 4T1.2 cells were harvested as described and resuspended to 2.5 Â 10 6 cells/ml in endotoxin-free phosphate-buffered saline. Cells in a 200 ml volume were injected into the tail vein of female Balb/c mice using a 0.5-ml insulin syringe (BD Biosciences, Bedford, MA, USA). After 14 days, mice were sacrificed and the lungs were harvested as described above.
Statistical analysis
Statistical analysis was performed on GraphPad Prism version 5.0. for Windows XP (GraphPad Software, San Diego, CA, USA). Unless otherwise stated, statistical test used for analysis was an unpaired two-tailed t-test with significance set as Po0.05. Western blot densitometry was performed with ImageJ 1.43U (developed by Wayne Rasband, National Institute of Health, Bethesda, MD, USA).
